CN1107511C - Specific medicine for treating common cold - Google Patents
Specific medicine for treating common cold Download PDFInfo
- Publication number
- CN1107511C CN1107511C CN 00100617 CN00100617A CN1107511C CN 1107511 C CN1107511 C CN 1107511C CN 00100617 CN00100617 CN 00100617 CN 00100617 A CN00100617 A CN 00100617A CN 1107511 C CN1107511 C CN 1107511C
- Authority
- CN
- China
- Prior art keywords
- radix
- medicine
- flos lonicerae
- fructus forsythiae
- rhizoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a specific medicine for treating common cold, which is prepared from bupleurum root, white peony alba, baikal skullcap root, pinellia tuber, honey-fried glycyrrhiza, ginseng, ginger, lonicera, weeping forsythia capsule, isatis root, rehmannia root, rhizoma anemarrhenae and bamboo leaf, and all the medicines are processed with a regular method comprising pulverization, stirring and uniform mixing. The specific medicine which is prepared from pure Chinese herbal medicines has the advantages of no toxic or side effect, obvious treating effect, high curing rate and radical treatment. The specific medicine which is matched with western medicine can treat warm and heat common cold and reduce the medicine resistance of the western medicine. The specific medicine has a health care function after being taken for a long time and has special treating effects on various kinds of common cold.
Description
The present invention relates to a kind of medicine for the treatment of flu, relate to specifically a kind ofly be prepared from, the flu disease is had the medicine of special efficacy by pure Chinese medicinal herbs.
At present, flu is common clinically a kind of difficult and complicated illness.All have sufferer to take place throughout the year, its infection rate, reinfection rate are high, and tend to occur a kind of like this symptom after the flu: sensation is slightly had a cold, and symptom is slight, and a burst of feels cold spine, and nose goes out steam, does not feel well.This condition of disease several months development, touching difficulty more.This disease is commonly called as " pestilence disease " and is meant exogenous cold partial heat, a dry partially class disease, and the bitter taste cigarette is done, unconsciously sweat and tire.Even the heating at night, i.e. begin heating after zero point, at the crack of dawn spontaneous regression.The feel dry mouth and throat of getting up next day is had a dizzy spell, and sees stars dark and dim eyesight.But the person's of being in a bad way the pure man is with anemia.The medicine of existing treatment flu clinically generally is that the lighter takes medicines such as Lonicerae and Forsythiae Powder, Herba Sidae Rhombifoliae granule, and weight person adopts fluid transport therapy.These therapy can only play interim additional, interim control, can not tackle the problem at its root, and also recurs easily later, and majority is in recurrence in the season of morbidity last time, has brought huge infringement for patient's life and health.Old friends expect to have a kind of cure rate height, and curative effect is fast, and the medicine that can thoroughly effect a radical cure flu comes out, to solve this common difficult and complicated illness clinically.
The inventor passes through a large amount of clinical practices and undergoes, achieve with reference to modern pharmacological research, from motherland's medicine treasure-house, filter out Radix Bupleuri, the Radix Scutellariae that to separate shaoyang channel heat, Flos Lonicerae, Fructus Forsythiae, the Radix Isatidis of energy heat-clearing and toxic substances removing, also filter out the Radix Rehmanniae, the Rhizoma Anemarrhenae, the Folium Bambusae of energy heat clearing away tonifying YIN, the Radix Ginseng of QI invigorating is held back the white peony root of liver, reach and transfer medicine Radix Glycyrrhizae Preparata, Rhizoma Zingiberis Recens, all medicines share, with play induce sweat diathermanous, heat-clearing and toxic substances removing, supplementing QI and nourishing YIN, the conditioning human internal milieu is so that patient's equilibrium between yin and yang is inside and outside sensible, overcome disease, will catch a cold and thoroughly cure.
The object of the present invention is to provide and a kind ofly form, have no side effect by pure Chinese medicinal herbs, the cure rate height, curative effect is fast, a kind of medicine for the treatment of flu that relapse rate is low.
The present invention seeks to realize like this: it is made up of Radix Bupleuri, the Radix Paeoniae Alba, Radix Scutellariae, the Rhizoma Pinelliae, Radix Glycyrrhizae Preparata, Radix Ginseng, Rhizoma Zingiberis Recens, Flos Lonicerae, Fructus Forsythiae, Radix Isatidis, the Radix Rehmanniae, the Rhizoma Anemarrhenae, Folium Bambusae, form through conventional method pulverizing, stirring, mixing, it is characterized in that it is the medicine that is prepared by following weight (g) proportion raw material
Radix Bupleuri 12, the Radix Paeoniae Alba 10,
Radix Scutellariae 3-15, the Rhizoma Pinelliae 10,
Radix Glycyrrhizae Preparata 10-20, Radix Ginseng 3-8,
Rhizoma Zingiberis Recens 3-5, Flos Lonicerae 10-60,
Fructus Forsythiae 10-60, Radix Isatidis 10-20,
Radix Rehmanniae 10-20, Rhizoma Anemarrhenae 5-15,
Folium Bambusae 3-100.
Its feature also is: described Radix Bupleuri is the wild black Radix Bupleuri in Shanxi, the described Radix Paeoniae Alba is a KANGBAISHAO, described Radix Scutellariae is the wild withered and yellow a kind of reed mentioned in ancient books in Shanxi, the described Rhizoma Pinelliae is positive QINGXIA, described Radix Glycyrrhizae Preparata is the wild Radix Glycyrrhizae in Shanxi, and described Radix Ginseng is a Dongbei Radix Ginseng Rubra, and described Flos Lonicerae is the assorted unopened Flos Lonicerae of fresh nothing, described Fructus Forsythiae is the Shanxi Fructus Forsythiae, and described Folium Bambusae is the QINGZHU leaf.
Its feature also is: described Flos Lonicerae, Fructus Forsythiae, Radix Isatidis, the Rhizoma Anemarrhenae and Folium Bambusae are through exsiccant under<40 ℃ of low temperature, the Flos Lonicerae of moisture content<10%, Fructus Forsythiae, Radix Isatidis, the Radix Rehmanniae, the Rhizoma Anemarrhenae and Folium Bambusae.
The present invention compared with prior art, it is to be made by pure Chinese herbal medicine, has no side effect, and is evident in efficacy, the cure rate height can thoroughly effect a radical cure, and cooperates with Western medicine and can treat warm flu, reducing the drug resistance of Western medicine, have health care through long taking, is a kind of medicine that various flu is had special efficacy.
Further specify the present invention below in conjunction with embodiment
Embodiment
1. be purchased and weigh (g) following clean medical material of high-quality that meets state health standards,
Wherein: the wild black Radix Bupleuri 12g in Shanxi, KANGBAISHAO 10g, the wild withered and yellow a kind of reed mentioned in ancient books 9g in Shanxi, positive QINGXIA 10g, the wild Radix Glycyrrhizae 15g in Shanxi, Dongbei Radix Ginseng Rubra 5g, Rhizoma Zingiberis Recens 4g, the fresh nothing unopened Flos Lonicerae 35g that mixes, Shanxi Fructus Forsythiae 35g, Radix Isatidis 15g, Radix Rehmanniae 15g, Rhizoma Anemarrhenae 10g, QINGZHU leaf 52g
2. above-mentioned Flos Lonicerae, Fructus Forsythiae, Radix Isatidis, the Rhizoma Anemarrhenae and Folium Bambusae is dry under<40 ℃ low temperature, to moisture content<10%,
3. with the raw material pulverize separately of said components, and cross 180 mesh sieves, each medicated powder end of 180 purposes,
4. with each powder mixes, stir,
5. be filled into capsule for medicine, every 0.5 gram promptly gets 450 a kind of specific drug capsules for the treatment of flu of the present invention.
6. also can be with above-mentioned medical material, make the concentrated capsule that meets pharmacopeia and require, dry-pressing sheet, the watered pill, small honey pill, oral liquid, electuary etc.
A kind of specific drug for the treatment of flu of the present invention cures mainly pathogenic heat and caves in, and stifling internal organs are controlled epidemic febrile disease defensive-qi-nutrient-blood disease simultaneously, and better curative effect is all arranged, and health care is still arranged.
A kind of specific drug for the treatment of flu of the present invention can be equipped with antibiotic, to improve curative effect, reduces the drug resistance of Western medicine.
Claims (3)
1, a kind of medicine for the treatment of flu, it is made up of Radix Bupleuri, the Radix Paeoniae Alba, Radix Scutellariae, the Rhizoma Pinelliae, Radix Glycyrrhizae Preparata, Radix Ginseng, Rhizoma Zingiberis Recens, Flos Lonicerae, Fructus Forsythiae, Radix Isatidis, the Radix Rehmanniae, the Rhizoma Anemarrhenae, Folium Bambusae, form through conventional method pulverizing, stirring, mixing, it is characterized in that it is the medicine that is prepared by the following weight proportion raw material:
Radix Bupleuri 12, the Radix Paeoniae Alba 10,
Radix Scutellariae 3-15, the Rhizoma Pinelliae 10,
Radix Glycyrrhizae Preparata 10-20, Radix Ginseng 3-8,
Rhizoma Zingiberis Recens 3-5, Flos Lonicerae 10-60,
Fructus Forsythiae 10-60, Radix Isatidis 10-20,
Radix Rehmanniae 10-20, Rhizoma Anemarrhenae 5-15,
Folium Bambusae 3-100.
2, a kind of specific drug for the treatment of flu according to claim 1, its feature also is: described Radix Bupleuri is the wild black Radix Bupleuri in Shanxi, the described Radix Paeoniae Alba is a Radix Paeoniae Alba, described Radix Scutellariae is the wild withered and yellow a kind of reed mentioned in ancient books in Shanxi, and the described Rhizoma Pinelliae is positive QINGXIA, and described Radix Glycyrrhizae Preparata is the wild Radix Glycyrrhizae in Shanxi, described Radix Ginseng is a Dongbei Radix Ginseng Rubra, described Flos Lonicerae is the assorted unopened Flos Lonicerae of fresh nothing, and described Fructus Forsythiae is the Shanxi Fructus Forsythiae, and described Folium Bambusae is the QINGZHU leaf.
3, a kind of specific drug for the treatment of flu according to claim 1, its feature also is: described Flos Lonicerae, Fructus Forsythiae, Radix Isatidis, the Rhizoma Anemarrhenae and Folium Bambusae are through exsiccant under<40 ℃ of low temperature, the Flos Lonicerae of moisture content<10%, Fructus Forsythiae, Radix Isatidis, the Radix Rehmanniae, the Rhizoma Anemarrhenae and Folium Bambusae.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 00100617 CN1107511C (en) | 2000-01-24 | 2000-01-24 | Specific medicine for treating common cold |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 00100617 CN1107511C (en) | 2000-01-24 | 2000-01-24 | Specific medicine for treating common cold |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1265895A CN1265895A (en) | 2000-09-13 |
CN1107511C true CN1107511C (en) | 2003-05-07 |
Family
ID=4575568
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 00100617 Expired - Fee Related CN1107511C (en) | 2000-01-24 | 2000-01-24 | Specific medicine for treating common cold |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1107511C (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8034387B2 (en) | 2002-04-30 | 2011-10-11 | Unigen, Inc. | Formulation of a mixture of free-B-ring flavonoids and flavans for use in the prevention and treatment of cognitive decline and age-related memory impairments |
BRPI0409179A (en) | 2003-04-04 | 2006-05-02 | Unigen Pharmaceuticals Inc | formulation of dual cyclooxygenase (cox) and lipoxygenase (lox) inhibitors for mammalian skin care |
CN1305521C (en) * | 2005-10-26 | 2007-03-21 | 牟培新 | Cold treating medicine |
KR100761248B1 (en) | 2006-10-12 | 2007-10-04 | 주식회사 유니젠 | Composition for treating atopic dermatitis comprising extracts of bamboo and scutellaria |
CN102091307B (en) * | 2010-12-06 | 2012-05-30 | 张瑾 | Traditional Chinese medicine composition for treating cold |
IT202000026566A1 (en) * | 2020-11-06 | 2022-05-06 | Herbal E Antioxidant Derivatives Srl Ed In Forma Abbreviata H&Ad Srl | COMBINATIONS OF NATURAL ANTIVIRAL AND ANTIMICROBIAL, THEIR USE AND FORMULATIONS CONTAINING THEM |
-
2000
- 2000-01-24 CN CN 00100617 patent/CN1107511C/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN1265895A (en) | 2000-09-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103463609A (en) | Traditional Chinese medicine oral decoction for treating upper respiratory infection and preparation method for Chinese patent medicine of traditional Chinese medicine oral decoction | |
CN104127531A (en) | Traditional Chinese medicine composition for treating enterogastritis and preparation method thereof | |
CN103536889A (en) | Traditional Chinese medicine decoction for treating senile chronic bronchitis complicated pulmonary emphysema | |
CN101130023A (en) | Stomach warming codonopsis powder | |
CN104971215A (en) | Traditional Chinese medicine composition for treating spleen-deficiency gastrasthenia type chronic gastritis and preparation method thereof | |
CN1931329A (en) | Stomatocase treating medicine | |
CN102302673B (en) | Traditional Chinese medicine compound preparation for preventing and treating diabetic nephropathy (DN) | |
CN1107511C (en) | Specific medicine for treating common cold | |
CN104958636A (en) | Medicinal composition for treating functional dyspepsia and preparation method of medicinal composition | |
CN104958536A (en) | Chinese medicinal composition for treating diabetes and preparation method thereof | |
CN103800580A (en) | Traditional Chinese medicinal prescription for treating adenoidal hypertrophy and preparation method thereof | |
CN104337994A (en) | Medicine for treating digestive tract cancers | |
CN1297310C (en) | Medicated liquor for curing chronic gastritis and gastric ulcer | |
CN100427138C (en) | Anti-diarrhea granule for infants | |
CN106511773A (en) | Traditional Chinese medicine composite for treating dental ulcer | |
CN103989762B (en) | Chinese medicine composition of internal organs relieving cough and resolving phlegm and preparation method thereof is rushed down in a kind of heat clearing away | |
CN113144108A (en) | A Chinese medicinal composition for treating coronavirus and preparation method thereof | |
CN1069053C (en) | Oral medicine for treating phlegm-heat cough | |
CN105381291A (en) | Traditional Chinese medicine composition for preventing and treating pneumonia, preparation method and applications thereof | |
CN105055657A (en) | Spraying agent for improving pain caused by wisdom teeth and preparation method thereof | |
CN104606600A (en) | Traditional Chinese medicine composition for treating interstitial lung disease and preparation method of composition | |
CN1191086C (en) | Medicine for treating cold in summer and autumn | |
CN1907406A (en) | Decoction preparation for treating asomnia of protracted disease intruding into collateral and its preparation process | |
CN105597011A (en) | Method for preparing traditional Chinese medicine composition for treating acute or chronic rhinitis | |
CN108785478A (en) | It is a kind of to treat fat Chinese medicine composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1058164 Country of ref document: HK |